JP7883442B2 - 新しい注射用油性医薬組成物 - Google Patents

新しい注射用油性医薬組成物

Info

Publication number
JP7883442B2
JP7883442B2 JP2022562978A JP2022562978A JP7883442B2 JP 7883442 B2 JP7883442 B2 JP 7883442B2 JP 2022562978 A JP2022562978 A JP 2022562978A JP 2022562978 A JP2022562978 A JP 2022562978A JP 7883442 B2 JP7883442 B2 JP 7883442B2
Authority
JP
Japan
Prior art keywords
agents
particles
core
drugs
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022562978A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522056A5 (cg-RX-API-DMAC10.html
JP2023522056A (ja
Inventor
ヨハンソン,アンドレス
ロース,マルテン
ヘルルプ,ヨエル
Original Assignee
ナネクサ・アクチボラグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ナネクサ・アクチボラグ filed Critical ナネクサ・アクチボラグ
Publication of JP2023522056A publication Critical patent/JP2023522056A/ja
Publication of JP2023522056A5 publication Critical patent/JP2023522056A5/ja
Application granted granted Critical
Publication of JP7883442B2 publication Critical patent/JP7883442B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022562978A 2020-04-17 2021-04-16 新しい注射用油性医薬組成物 Active JP7883442B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2005593.5A GB202005593D0 (en) 2020-04-17 2020-04-17 New composition
GB2005593.5 2020-04-17
PCT/GB2021/050913 WO2021209762A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition

Publications (3)

Publication Number Publication Date
JP2023522056A JP2023522056A (ja) 2023-05-26
JP2023522056A5 JP2023522056A5 (cg-RX-API-DMAC10.html) 2024-04-19
JP7883442B2 true JP7883442B2 (ja) 2026-07-01

Family

ID=70860026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022562978A Active JP7883442B2 (ja) 2020-04-17 2021-04-16 新しい注射用油性医薬組成物

Country Status (9)

Country Link
US (1) US20230157968A1 (cg-RX-API-DMAC10.html)
EP (1) EP4135672A1 (cg-RX-API-DMAC10.html)
JP (1) JP7883442B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230004568A (cg-RX-API-DMAC10.html)
CN (1) CN116075295A (cg-RX-API-DMAC10.html)
AU (1) AU2021256075A1 (cg-RX-API-DMAC10.html)
CA (1) CA3179556A1 (cg-RX-API-DMAC10.html)
GB (1) GB202005593D0 (cg-RX-API-DMAC10.html)
WO (1) WO2021209762A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023105227A1 (en) * 2021-12-08 2023-06-15 Nanexa Ab New injectable combination formulation
GB2619556A (en) * 2022-06-10 2023-12-13 Nanexa Ab New process
AU2023392764A1 (en) * 2022-12-15 2025-06-19 Nanexa Ab New pharmaceutical compositions comprising glucagon-like peptide-1 receptor agonists
GB202218958D0 (en) 2022-12-15 2023-02-01 Nanexa Ab New pharmaceutical composition
CN117844877B (zh) * 2024-01-14 2024-09-06 宿州市东凯医药科技有限公司 一种通过生物酶制备普瑞巴林的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015110637A (ja) 2008-09-04 2015-06-18 アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc 非水性担体を用いた徐放性製剤
JP2019142913A (ja) 2013-05-24 2019-08-29 ナネクサ・アクチボラグ 無機物コーティングを持つ固体ナノ粒子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097742B2 (en) 2005-01-20 2012-01-17 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015110637A (ja) 2008-09-04 2015-06-18 アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc 非水性担体を用いた徐放性製剤
JP2019142913A (ja) 2013-05-24 2019-08-29 ナネクサ・アクチボラグ 無機物コーティングを持つ固体ナノ粒子

Also Published As

Publication number Publication date
WO2021209762A1 (en) 2021-10-21
US20230157968A1 (en) 2023-05-25
GB202005593D0 (en) 2020-06-03
JP2023522056A (ja) 2023-05-26
KR20230004568A (ko) 2023-01-06
CA3179556A1 (en) 2021-10-21
AU2021256075A1 (en) 2022-11-03
CN116075295A (zh) 2023-05-05
EP4135672A1 (en) 2023-02-22

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240408

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250325

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250326

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260410

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260522

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260619

R150 Certificate of patent or registration of utility model

Ref document number: 7883442

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150